Addressing unmet needs in rare diseases and systemic complement mediated disorders
Essential Medicines for Hemophilia and other rare bleeding disorders
Greater Convenienc
A leader in the field of engineered protease biopharmaceuticals
Greater Convenience
Protease engineering platform – hemophilia assets in development and a SQ systemic complement research program
Learn more about our Pipeline
SQ Marzeptacog alfa (activated) MarzAA (FVIIa)
Phase 3
CB 2782-PEG
IVT Anti-C3 Dry AMD
CB 4332 SQ Enhanced CFI
SQ Systemic Complement Degraders
SQ MarzAA (FVIIa)
SQ Dalcinonacog alfa – DalcA (FIX)
Factor IX Gene Therapy
Factor Xa
Learn more about the medicines we are developing
See our pipeline
Share our passion about treating disease
See our publications
Learn more about the Catalyst team and mission/culture
Meet the team